Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024
Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmicals收到纳斯达克未能满足继续上市规则通知及首席执行官Anatoly Dritschilo将出席2024年3月6日新兴增长会议